Objective: To assess the effect of race on the incidence of aortic stenosis (AS) and utilization and outcomes of aortic valve replacement (AVR). Patients and Methods: Patients older than 60 years hospitalized with a primary diagnosis of AS and those who underwent AVR between 2003 and 2014 were included. Adjusted and unadjusted incidence of ASrelated hospitalizations, utilization rates of AVR, in-hospital morbidity and mortality, and resource utilization was compared between whites and African Americans (AAs). Results: Between January 1, 2003, and December 31, 2014, the incidence of AS-related admissions increased from 13 (95% CI, 12.8-13.2) to 26 (95% CI, 25.7-26.4) cases per 100,000 patient-years in whites and from 3 (95% CI, 3.5-3.8) to 9.5 (95% CI, 9.4-9.8) cases per 100,000 patient-years in AAs (P<.001). The incidence density ratio decreased from 4.3 (95% CI, 2.27-6.6) in 2003 to 2.7 (95% CI, 1.1-3.8) in 2014. The ratio of AVR to AS-related admissions was 11.3% in whites and 6.7% in AAs (P<.001). Crude in-hospital mortality after AVR was higher in AAs (6.4% vs 4.7%; P<.001). However, after propensity score matching, in-hospital morality after isolated AVR was not significantly different between AAs and whites (4.7% vs 3.7%; P¼.12). African Americans also had longer hospitalizations (12AE12 days vs 10AE9 days; P<.001), higher rates of nonhome discharge (32.1% vs 27.2%; P¼.004), and higher cost of hospitalization ($55,631AE$37,773 vs $52,521AE$38,040; P<.001). Conclusions: African Americans undergo AVR less than whites. The underlying etiology of this disparity is multifactorial, but may be related to a lower incidence of AS in AAs. Aortic valve replacement is associated with similar risk-adjusted in-hospital mortality but higher cost and longer hospitalizations in AAs than in whites.
A frican American (AA) race has been identified as an independent risk factor for postoperative morbidity and mortality after coronary artery bypass grafting (CABG) and heart transplantation. [1] [2] [3] [4] These findings have been partially attributed to differences in risk profile, socioeconomic factors, and hospital characteristics. 4 However, the differential effect of race on the outcomes of isolated surgical aortic valve replacement (AVR) operations has been debated. 5 With the increasing burden of aortic stenosis (AS) and the dramatic change in its management in the past decade, there is a need to understand contemporary racial differences in the utilization and outcomes of AVR. We aim to use the Nationwide Inpatient Sample (NIS) to describe the differences in clinical risk profile of white and AA patients undergoing AVR and to investigate disparities in AVR utilization rates, in-hospital outcomes, resource utilization, and cost of care between white and AA patients.
PATIENTS AND METHODS

Study Data
The NIS was used to derive patient relevant information between January 1, 2003, and December 31, 2014. The NIS is the largest publicly available all-payer administrative claimsebased database and contains information about patient discharges from approximately 1000 nonfederal hospitals in 45 states. It contains clinical and resource utilization information on 5 to 8 million discharges annually, with safeguards to protect the privacy of individual patients, physicians, and hospitals. These data are stratified to represent approximately 20% of US inpatient hospitalizations across different hospital and geographic regions (random sample). The national estimates of the entire US hospitalized population were calculated using the Agency for Healthcare Research and Quality sampling and weighting method. 
Study Population
Racial Disparity in AS-Related Hospitalization and AVR Utilization
To investigate the possible effect of race on the utilization rates of AVR, we calculated the following:
1. The incidence of AS-related admissions, defined as hospital admissions with a principal diagnosis of aortic valve disease in patients older than 60 years. The total number of whites and AAs were derived from the US Census data. 2. The incidence density ratio, defined as relative difference in AS-related admissions between white patients and their AA counterparts. 3. The ratio of AVR to AS-related admissions in both races. The trends in AVR utilization over the study period were assessed using the Mann-Kendall test.
Comparative Outcomes Analysis
We aimed to perform a comparative outcomes analysis between white and AA patients undergoing AVR. To account for potential confounding factors and reduce the effect of selection bias, a vigorous propensity scoree matching model was developed using logistic regression to derive 2 matched groups for comparative outcomes analysis. After excluding patients who underwent concomitant cardiac operation, patients who underwent "isolated" AVR were entered into a nearest-neighbor 1:1 variable ratio, parallel, balanced propensity scoreematching model using a caliper of 0.01 without replacement to ensure perfect matching. Variables included in the propensity scoreematching model are listed in Supplemental Table 1 (available online at http://www.mayoclinicproceedings. org). Patients with missing race data were excluded. To estimate the cost of hospitalization, the NIS data were merged with cost-tocharge ratios available from the Healthcare Cost and Utilization Project. We estimated the cost of each inpatient stay by multiplying the total hospital charge with cost-to-charge ratios. The primary end point was in-hospital death. Secondary end points included procedural mortality (defined as death occurring on the same hospital day as AVR), vascular complications, pacemaker implantation, transient ischemic attack, cerebral vascular accidents, blood transfusion, acute kidney injury requiring dialysis, cardiac tamponade, hospital length of stay, cost of hospitalization, and discharge disposition.
Statistical Analyses
Descriptive statistics were presented as frequencies with percentages for categorical variables and as means with SDs for continuous variables. Baseline characteristics were compared using the Pearson chi-square test and Fisher exact test for categorical variables and the independent-samples t test for continuous variables. Univariate and multivariate logistic regression was performed to estimate odds ratios with 95% CIs to determine predictors of in-hospital death. Matched categorical variables were presented as frequencies with percentages and compared using the McNemar test. Matched continuous variables were presented as means with SDs and compared using a paired samples t test. A type I error rate of less than .5 was considered statistically significant. All statistical analyses were performed using SPSS version 24 (IBM Corporation) and R version 3.3.1 (R Foundation for Statistical Computing).
RESULTS
Between January 1, 2003, and December 31, 2014, the incidence of AS-related admissions increased from 13 (95% CI, 12.8-13.2) to 26 (95% CI, 25.7-26.4) cases per 100,000 patient-years in whites and from 3 (95% CI, 3.5-3.8) to 9.5 (95% CI, 9.4-9.8) cases per 100,000 patient-years in AAs (P<.001) (Figure 1, A) . The incidence density ratio (ratio of AS-related admission in whites and AAs) decreased from 4.3 (95% CI, 2.27-6.6) in 2003 to 2.7 (95% CI, 1.1-3.8) in 2014. A total of 96,728 patients who were identified as whites or AAs underwent AVR during the study period (weighted national estimates, 478,813 patients), of whom 92,469 (95.6%) were whites and 4259 (4.4%) were AAs. The ratio of AVR to AS-related admissions was 11.3% in whites and 6.7% in AAs (P<.001), and this ratio remained constant throughout the study period (Figure 1, B) . Baseline characteristic profiles were distinctly different between whites and AAs, as detailed in Table 1 . Compared with whites, AAs were younger (72AE7 years vs 74AE8 years; P<.001) and had a lower percentage of male patients (51.7% vs 61.3%; P<.001). African Americans had a higher prevalence of hypertension, diabetes, anemia, and chronic renal disease. In contrast, coronary artery disease and previous sternotomy were more prevalent Unadjusted in-hospital mortality was significantly higher in AAs than in whites (6.4% vs 4.7%; P<.001) ( Table 2 ). Although mortality rates decreased in both whites and AAs over time, the racial gap remained constant throughout the study period (Supplemental Figure 1 , available online at http://www.mayoclinicproceedings.org). African Americans also had a higher incidence of stroke (3.9% vs 2.7%; P<.001), acute kidney injury requiring dialysis (3.0% vs 1.8%; P<.001), and blood transfusion (42.3% vs 40.0%, P¼.003). The length of hospital stay was longer in AAs than in whites (14AE13 vs 11AE10; P<.001), and this was associated with a significantly higher cost of care ($62,829AE$45,168 vs $55,811AE$38,657; P<.001) (Supplemental Table 2 , available online at http://www.mayoclinicproceedings.org).
Also, AAs were more likely than whites to be discharged to a nursing home or intermediate care facility (35.7% vs 32.1%; P<.001). When hospitals were stratified by AVR volumes, in-hospital mortality was found to be consistently higher in AAs, although it was only statistically significant in high-volume centers (P<0.001). The influence of hospital AVR volume on postoperative morbidities, length of stay, and resource utilization is illustrated in Supplemental Tables 3 and 4 (available online at http://www.mayoclinicproceedings.org).
Outcomes of Isolated AVR
Of the 96,728 study patients, 45,703 (47.2%) underwent isolated AVR. Of those, 43,531 (95.2%) were whites and 2172 (4.8%) were AAs. Unadjusted in-hospital mortality after isolated AVR was higher in AAs than in whites (4.8% vs 3.1%; P<.001). Complete details of the baseline characteristics and in-hospital outcomes of these patients (unmatched groups) are listed in Supplemental Tables 5  and 6 (available online at http://www. mayoclinicproceedings.org). Propensity score matching yielded 2129 matched pairs of white and AA patients who underwent isolated AVR (Supplemental Figure 2 , available online at (Table 3) . After propensity score matching, in-hospital mortality was higher in AAs, but this was not statistically significant (4.7% vs 3.7%; P¼.12) (Figure 2 ). Stroke, acute kidney injury requiring dialysis, and blood transfusion were similar in white and AA patients (3.1% vs 3.4%, 2.4% vs 2.4%, and 40.5% vs 41.9%, respectively) ( ($55,631AE$37,773 vs $52,521AE$38,040;
P<.001).
A subgroup analysis of in-hospital mortality in the propensity scoreematched cohorts was performed to identify possible racial disparity in AVR outcomes in certain subgroups of patients. In this analysis, white patients who were younger than 80 years, nondiabetics, and those with chronic obstructive lung disease or without previous sternotomy had significantly lower in-hospital mortality than did their propensity scoreematched AA counterparts (adjusted odds ratio, 0.66; 95% CI, 0.47-0.930; P¼.017, adjusted odds ratio, 0.65; 95% CI, 0.45-0.95; P¼.026, adjusted odds ratio, 0.71; 95% CI, 0.50-0.99; P¼.049, and adjusted odds ratio, 0.73; 95% CI, 0.53-0.99; P¼.049, respectively) ( Figure 3 ).
DISCUSSION
The principal findings of the present investigations are as follows: (1) AS-related admissions are less common in AAs than in whites, suggesting a lower incidence of AS in the AA population; (2) among patients admitted with AS, AAs are less likely to undergo AVR than whites; (3) AAs had higher unadjusted inhospital mortality after AVR than did whites. However, after adjusting for age, sex, clinical risk factors, hospital characteristics, and socioeconomic status, the differences in in-hospital mortality between the 2 groups became statistically nonsignificant; and (4) AVR (isolated or concomitant with other cardiac operation) in AAs is associated with higher resource utilization (length of stay, nursing home and intermediate care usage, and cost) compared with whites.
Aortic valve stenosis has been an area of extensive research in the past decade because of the increasing burden of AS and the impressive expansion in its treatment options. It is therefore important to understand risk factors for this disease. To our knowledge, our study is the first nationwide study to date to report a lower incidence of AS-related hospitalizations in AAs than in whites. Because these hospitalization incidence rates reflect elective and nonelective admissions, they are less susceptible to referral bias and these data may therefore suggest a lower prevalence of severe calcific AS in AAs than in whites. This is supported by recent studies suggesting a lower prevalence of severe AS in AAs than in whites. [6] [7] [8] [9] In the largest of these studies, Patel et al 9 examined 272,525 transthoracic echocardiograms (81.8% whites and 13.5% AAs) and found that the prevalence of severe AS was 0.91% in whites compared with 0.29% in AAs (adjusted odds ratio, 0.47; 95% CI, 0.36-0.61). To rule out referral bias against patients with severe valvular heart disease, the authors assessed racial disparity in the prevalence of severe mitral regurgitation and found this prevalence to be similar in whites and AAs (1.35% vs 1.45%, respectively). The underlying etiology of this racerelated difference in the incidence/prevalence of severe AS may be related to (1) the shorter life expectancy in AAs than in whites (3.5 years in 2015) 10 ; (2) a lesser severity of AS in AAs than in their white counterparts. African American patients have less aortic valve thickness, lower incidence and progression of coronary artery calcifications, and lower incidence of extracardiac calcifications than do white patients [11] [12] [13] [14] ; and (3) racial differences in clinical risk factors, genetic precursors, and environmental exposures. However, there are no sufficient data pertinent to the contribution of these differences to the incidence and progression of AS in whites and AA patients. 9, 15 Further studies are needed to confirm the magnitude and underlying etiologies of these suggested race-related differences in the prevalence of AS.
Our study also affirms previous findings that the percentage of AA patients undergoing AVR is less than a quarter of their percentage of the overall population. In a large cohort of Medicare patients who underwent AVR between 1999 and 2011, AA patients represented less than 3.2% of the total cohort. 16 Similarly, of the 54,782 patients who underwent transcatheter AVR in the United States up to December 31, 2015, only 3.8% were AAs. 17 These extremely low utilization rates of AVR in AAs are likely multifactorial and may be due to (1) a lower prevalence of AS in AAs; (2) a racial disparity in referral for AVR even in patients admitted with AS 7, 18 ; and (3) cultural and other barriers leading to patient's refusal of surgery. 7 Our findings support the first 2 explanations by indicating a higher incidence of AS-related admissions in AAs, yet a lower utilization rate of AVR in those who are admitted with AS. Whether disease severity at admission and invasiveness of AVR play a role in proceeding with definitive treatment in the racial group remains unknown. Nevertheless, we recently found no significant racial disparity in the uptake rates presenting symptoms between the 2 groups; most white patients were men (61.3%), whereas there was an equal distribution of sex among AAs undergoing AVR (51.7% men vs 48.3% women). African Americans had a higher incidence of hypertension and diabetes than did whites, but counterintuitively they had a lower incidence of coronary artery disease and previous sternotomy. Utilization rates of nonelective AVR were substantially higher in AAs (45.2% vs 31.3%; P<.001), who also had a higher incidence of cardiogenic shock at presentation (6.2% vs 3.8%; P<.001). Nonelective admission status is an established independent predictor of inhospital mortality. 20 African Americans were more likely to have a lower median household income, to be uninsured, and to be treated at urban and teaching hospitals.
Resource utilization profiles revealed striking differences between the 2 groups. African Americans were much more likely to receive AVR during nonelective admission than whites (31.3% vs 45.2%; P<.001). This can possibly be related to less vigorous outpatient surveillance and/or reluctance of AAs to undergo elective AVR compared with white patients. 7 In-hospital length of stay was also longer and cost of care and discharges to intermediate care facilities were significantly higher in AAs despite similar morbidity and mortality compared with white patients. Similar findings of higher resource utilization in AAs have been reported after coronary stenting and CABG, with a possible role of hospital quality and volume in the disparity in cost and resource utilization. 21, 22 This study has a number of limitations:
1. The NIS is an administrative database that collects data for billing purposes and can be limited by erroneous coding. However, the database is subject to vigorous quality control measures that should minimize these possibilities. Furthermore, the hard clinical end points used in our analysis (in-hospital mortality) are difficult to miscode. 2. It is not possible to identify racial disparity in the symptoms, diagnosis, and referral for treatment from this database. Therefore, our findings of a lower incidence of ASrelated hospitalizations in AAs should be viewed as hypothesis generating and warrant further confirmatory studies. 3. The NIS allows detailed assessment of inhospital outcomes. However, baseline and postprocedural laboratory and echocardiographic data are not captured. Also, longterm mortality data are unavailable in this database. 4. The potential for unmeasured confounders may bias the outcome results in the propensity scoreematched cohorts. However, we believe that our rigorous propensity score matching has adequately addressed this selection bias.
CONCLUSION
In this contemporary nationwide analysis, AAs constituted only 4.4% of patients undergoing AVR for AS. The lower utilization rate of AVR in AAs is multifactorial, but may be partially due to a lower incidence of AS in this population. Among patients who underwent AVR, crude inhospital mortality is higher in AAs, but after adjustment for clinical characteristics, socioeconomic risk factors, and hospital characteristics, this excess mortality became nonstatistically significant. In addition, AVR in AAs was associated with longer hospitalizations, higher cost, and higher utilization of intermediate care facilities.
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